Was a Potential New Cancer Treatment Covered Up? | ENDEVR Documentary

The War On Cancer, launched in the early 1970s, set the stage for a massive influx of new
ideas in fighting the disease of cancer. Memorial Sloan-Kettering Cancer Center, America's
leading cancer research center at the time, was assigned the task of testing an unconventional
therapy called “Laetrile” in an effort to curb the public’s “false hope” in the alleged “quack”
therapy.

Ralph W. Moss PhD, a young and eager science writer, was hired by Sloan-Kettering’s public
relations department in 1974 to help brief the American public on the center’s contribution
to the War On Cancer. One of his first assignments was to write a biography about Dr.
Kanematsu Sugiura, one of the Center’s oldest and leading research scientists as well as the
original co-inventor of chemotherapy.

Ways To Support This Channel:
EMF PROTECTION
https://www.emfsol.com/?aff=cyhelka1%2540gmail.com
B17 and apricot seeds
https://rncstore.com/r?id=rimktc

Health Ranger Store
https://www.healthrangerstore.com/?rfsn=7259889.9ac1ad8&utm_source=HR_Affiliate&utm_campaign=14708&utm_affiliate=7259889